Alterations of Mesenchymal and Endothelial Cells in Inflammatory Bowel Diseases-Reference-Cited by-同舟云学术

Alterations of Mesenchymal and Endothelial Cells in Inflammatory Bowel Diseases

Published:2006 Issue: Volume: Page:168-176
ISSN:0065-2598
Container-title:Immune Mechanisms in Inflammatory Bowel Disease
language:
Short-container-title:

Author:

Fiocchi Claudio,Ina Kenji,Danese Silvio,Leite André Z. A.,Vogel Jon D.

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/0-387-33778-4_11

Reference53 articles.

1. Smith JB, Haynes MK. Rheumatoid arthritis-A molecular understanding. Ann Intern Med 2002; 136:908–922.

2. Fiocchi C. Intestinal inflammation: A complex interplay of immune-non immune cell interactions. Am J Physiol 1997; 273:G769–G775.

3. Pucilowska JB, Williams KL, Lund PK. Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: Cellular mediators and animal models. Am J Physiol 2000; 279:G653–G659.

4. Lund PK, Zuniga CC. Intestinal fibrosis in human and experimental inflammatory bowel disease. Curr Opin Gastroenterol 2001; 17:318–323.

5. Schmitt-Graff A, Desmouliere A, Gabbiani G. Heterogeneity of myofibroblast phenotypic features: An example of fibroblast cell plasticity. Virchows Archiv 1994; 425:3–24.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Endothelial-to-Mesenchymal Transition in Cardiovascular Disease;Cells;2022-06-03

2. Defining human mesenchymal and epithelial heterogeneity in response to oral inflammatory disease;eLife;2021-01-04

3. Defining human mesenchymal and epithelial heterogeneity in response to oral inflammatory disease;2020-09-02

4. Drug discovery approaches to irritable bowel syndrome;Expert Opinion on Drug Discovery;2015-07-21

5. Inflammation: An Equal-Opportunity Process;Digestive Diseases and Sciences;2011-01-25